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Sean Miller
Alternative Splicing 
• Process of creating multiple, unique gene products from one gene
• Splicing of pre-mRNA, inclusion and exclusion of different exons 
• Formation of different protein isoforms 
• Isoforms carry out unique functions 
• Allows for protein diversity (~20k genes, yet millions of unique proteins)
Sun, Q. (2018). “Homoharringtonine regulates the alternative splicing of Bcl-x and caspase 9 through a protein phosphatase 1-dependent mechanism.” BMC Complement & Alternative Medicine, 18(164).
What is Sam68?
• Sam68 is one of many proteins that carries 
out the process of alternative splicing 
• Splices pre-mRNA of many genes involved 
in cell growth, cell cycle regulation, and 
apoptosis  
• BCL2L1, SRSF1, and many more
• Has been shown to physically associate 
with many proteins playing roles in many 
other cellular processes 
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 Involved in AS and RNA metabolism 
 Alternatively splices the RNA transcripts of BIN, BIM, and MCL1
 Proteins heavily involved in apoptosis 
 Overexpressed in different cancer types 
 Overexpression has been shown to cause the formation of anti-
apoptotic isoforms of the above proteins 
 Sam68 can splice to a NMD isoform or the functional isoform 
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Frisone, P. et. al., (2015). “SAM68: Signal Transduction and RNA Metabolism in Human Cancer.” BioMed Research International, 1-14.
BCL2L1
 Heavily involved in apoptosis 
 BCL2L1 is spliced into two major 
isoforms: Bcl-X(L) and BCL-X(S) 
 BCL-X(L) sequesters pro-apoptotic proteins
 BCL-X(S) cannot sequester pro-apoptotic 
proteins, thus allowing for apoptosis
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Frisone, P. et. al., (2015). “SAM68: Signal Transduction and RNA Metabolism in Human Cancer.” BioMed Research International, 1-14.
Sam68 Protein-Protein Interactions
 Sam68 also plays a role in many 
cellular functions via protein-
protein interactions 
 Ex: Sam68 has been shown to play 
a role in transcription regulation
 Sam68 physically interacts with p53, 
a pro-apoptotic transcription factor 
 Sam68-p53 complex increases 
transcription of p53-transcribed 
genes
 p53 transcribes pro-apoptotic genes 
in response to DNA damage
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Simian Virus 40 Large T-antigen as a 
Model 
 Oncogenic viral protein
 Interferes with many cell cycle regulators resulting in tumorigenesis
 Goal is to deregulate the cell cycle
 > 12% of human cancers are caused by oncogenic viruses
 Human papillomavirus, Epstein-Barr virus, hepatitis B and C, etc.
Human Diploid Fibroblast Cells 
 Immortalized by telomerase 
 No limit on amount of cell divisions 
 HDF(Tert) cells are WT and do not express T-antigen 
 HDF(Tert) + T Clone cells have been transformed to 
express T-antigen 
 Clones: T-antigen implements into the genome at 
different locations 
 HDF(Tert) cells stably transfected with exogenous T-
antigen 
Experimental Question: 
What is Sam68’s role in T-antigen transformation? 
How much is Sam68 expressed in T-antigen 
expressing cells, and how does this impact Sam68’s 
ability to splice RNA and its protein interactions? 
Experimental Procedures 
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Functions/Targets of Sam68
 SRSF1 concentrations do not seem to be significantly different 
across cell lines
 Past lab data shows slight increase in SRSF1 in transformed cells
 Examination of other Sam68 mRNA targets
 What isoforms of BCL2L1 does Sam68 overexpression favor?
 Are there different isoforms of SRSF1 being expressed? 
 Because Sam68 seems mostly nuclear in our cells, this rules out 
cytoplasmic functions of Sam68
 Cytoplasmic Sam68 is involved in signal transduction 
Nuclear
Sam68
BCL2L1
SRSF1
MAPK
Src
PCR
2,000
1,500
1,200
1,000
900
800
700
600
500
400
300
200
100
*Unpublished Data
Bcl-X(L): 710 bps
(Anti-Apoptotitic)
Bcl-X(S): 513 bps
(Pro-Apoptotic) 
200
100
Sam68
BCL2L1
SRSF1
BIN
BIM
MCL1
Anti-Apoptosis
Bcl-X(L)
Pro-Apoptosis
Bcl-X(S)
p53
Sam68
p53
p21
MDM2BAX
Apoptosis
?
T-antigen Targeting of Regulatory 
Proteins  
• p53 is found in higher 
concentrations in cells expressing 
T-antigen
• Binds to p53 (normally unstable in 
health cell), stabilizing it and 
keeping it present in the cell
• Sam68 is also found in higher 
concentrations in T-antigen-
expressing cells
• Could T-antigen bind and sequester 
Sam68 in a similar way to p53?  
• Possible T-antigen/ Sam68/ p53 
complex? 
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Review of the Data
 Sam68 splicing in T-antigen-expressing vs. WT 
HDF(Tert) cells 
 SRSF1 is not being expressed in significantly different 
levels 
 BCL2L1 is not being alternatively spliced in a 
significantly different way
 Sam68 does not appear to interact with T-antigen 
at a detectable amount 
 Co-IP will need to be repeated 
Future Experiments 
 Examine isoforms of other Sam68 pre-mRNA targets 
 Cyclin D1, mTOR, Survivin
 Shifting view in our lab that Sam68 may be so highly 
expressed due to protein-protein interactions 
 Sam68 is an alternative splicing protein but also plays role in 
cellular functions via protein-protein interactions
 No difference in Sam68-spliced transcripts noted in our lab, 
so it seems more likely Sam68’s protein interactions are 
altered 
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